You are here:
NICE
NICE Guidance
Published Guidance
The clinical effectiveness and cost effectiveness of bupropion (Zyban) and Nicotine Replacement Therapy for smoking cessation
Technology appraisal guidance
Reference number:
TA39
Published:
27 March 2002
This guidance has been updated and replaced by
NICE guideline PH10
.